Impact of Magnesium Supplementation on Blood Pressure: An Umbrella Meta-Analysis of Randomized Controlled Trials

Impact of Magnesium Supplementation on Blood Pressure: An Umbrella Meta-Analysis of Randomized Controlled Trials

Background and aim: Conflicting results on the effect of magnesium supplementation on blood pressure have been published in previous meta-analyses; hence, we conducted this umbrella meta-analysis of RCTs to provide a more robust conclusion on its effects. Methods: Four databases including PubMed, Sc...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdullah M Alharran, Mooza M Alzayed, Parsa Jamilian, Kousalya Prabahar, Aminah Hassan Kamal, Muteb N Alotaibi, Omar E Elshaer, Mshal Alhatm, Mohd Diya Masmoum, Benjamin Hernández-Wolters, Raghad Sindi, Hamed Kord-Varkaneh, Ahmed Abu-Zaid
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Current Therapeutic Research
Subjects:
blood pressure
magnesium
systematic review
umbrella of meta-analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X24000250
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and aim: Conflicting results on the effect of magnesium supplementation on blood pressure have been published in previous meta-analyses; hence, we conducted this umbrella meta-analysis of RCTs to provide a more robust conclusion on its effects. Methods: Four databases including PubMed, Scopus, EMBASE, and Web of Science were searched to find pertinent papers published on international scientific from inception up to July 15, 2024. We utilized STATA version 17.0 to carry out all statistical analyses (Stata Corporation, College Station, TX, US). The random effects model was used to calculate the overall effect size ES and CI. Findings: Ten eligible review papers with 8610 participants studied the influence of magnesium on SBP and DBP. The pooling of their effect sizes resulted in a significant reduction of SBP (ES = -1.25 mmHg; 95% CI: -1.98, -0.51, P = 0.001) and DBP (ES = -1.40 mmHg; 95% CI: -2.04, -0.75, P = 0.000) by magnesium supplementation. In subgroup analysis, a significant reduction in SBP and DBP was observed in magnesium intervention with dosage ≥400 mg/day (ES for SBP = -6.38 mmHg; ES for DBP = -3.71mmHg), as well as in studies with a treatment duration of ≥12 weeks (ES for SBP = -0.42 mmHg; ES for DBP = -0.45 mmHg). Implications: The findings of the present umbrella meta-analysis showed an overall decrease of SBP and DBP with magnesium supplementation, particularly at doses of ≥400 mg/day for ≥12 weeks.
ISSN:0011-393X

Similar Items